• No results found

Anaplastic Astrocytoma

Prognostic Factors in Recurrent Glioblastoma Multiforme and Anaplastic Astrocytoma Treated with Selective Intra arterial Chemotherapy

Prognostic Factors in Recurrent Glioblastoma Multiforme and Anaplastic Astrocytoma Treated with Selective Intra arterial Chemotherapy

... RESULTS: Of 46 patients included in this study, 41 underwent evaluation. Thirty were male and 11 were female; mean age was 48.5 years. Karnofsky scores ranged from 70 to 100. Thirty- two patients had glioblastoma ...

8

Effectiveness of interferon beta and temozolomide combination therapy against temozolomide refractory recurrent anaplastic astrocytoma

Effectiveness of interferon beta and temozolomide combination therapy against temozolomide refractory recurrent anaplastic astrocytoma

... 2. Yung WK, Prados MD, Yaya-Tur R, Rosenfeld SS, Brada M, Friedman HS, Albright R, Olson J, Chang SM, O'Neill AM, Friedman AH, Bruner J, Yue N, Dugan M, Zaknoen S, Levin VA: Multicenter phase II trial of temozolomide in ...

5

Cellular and vaccine therapeutic approaches for gliomas

Cellular and vaccine therapeutic approaches for gliomas

... (A): astrocytoma; (AA): anaplastic astrocytoma; (alloCTL): alloreactive cytotoxic T lymphocytes; (AODG): anaplastic oligodendroglioma; (ALT): autologous lymphocyte transfer; (BTSC): brain ...

10

Temozolomide with Radiotherapy for the Treatment of Malignant Gliomas: Center Experience

Temozolomide with Radiotherapy for the Treatment of Malignant Gliomas: Center Experience

... In our retrospective study, between 2007 and 2009 twenty patients data were collected all patients had pathologically confirmed anaplastic astrocytoma (AA) or glioblastoma multiforme (GBM) who received TMZ ...

8

IDH1 Mutation in Gliomas in Baghdad by Immunohistochemical Study

IDH1 Mutation in Gliomas in Baghdad by Immunohistochemical Study

... grade astrocytoma and oligodendroglial tumors had the greatest values of IDH1 positivity (87%, 80% and ...by anaplastic astrocytoma (42%), then primary glioblastoma multiforme ...

7

Carbon ion radiotherapy boost in the treatment of glioblastoma: a randomized phase I/III clinical trial

Carbon ion radiotherapy boost in the treatment of glioblastoma: a randomized phase I/III clinical trial

... CIRT boost to the residual tumor in malignant glioma patients [GBM or anaplastic astrocytoma (AA)] that can be given to patients in addition to adjuvant radio- therapy at the standard dose (i.e., 60 GyE in ...

12

Comparing Perfusion Metrics Obtained from a Single Compartment Versus Pharmacokinetic Modeling Methods Using Dynamic Susceptibility Contrast Enhanced Perfusion MR Imaging with Glioma Grade

Comparing Perfusion Metrics Obtained from a Single Compartment Versus Pharmacokinetic Modeling Methods Using Dynamic Susceptibility Contrast Enhanced Perfusion MR Imaging with Glioma Grade

... versus anaplastic astrocytoma and low-grade oligodendroglioma versus low-grade ...low-grade astrocytoma versus low-grade oligodendroglioma and anaplastic astrocytoma versus glioblastoma ...

8

Favorable Ki 67 immunohistochemical Expression in low grade and high grade gliomas

Favorable Ki 67 immunohistochemical Expression in low grade and high grade gliomas

... Pilocytic Astrocytoma,12 Diffuse Astrocytoma, 13 Ependymoma, 5 Oligodendroglioma, 2 Diffuse Fibrillary Astrocytoma, 2 Gemistocytic Astrocytoma, 2 Myxopapillary Ependymoma, 2 subependymal giant ...

6

Ketolytic and glycolytic enzymatic expression profiles in malignant gliomas: implication for ketogenic diet therapy

Ketolytic and glycolytic enzymatic expression profiles in malignant gliomas: implication for ketogenic diet therapy

... Methods: Immunohistochemistry was performed on formalin fixed paraffin embedded sections from 22 brain biopsies (17 GBM, 3 anaplastic astrocytoma and 2 anaplastic oligoastrocytoma) using antibodies ...

6

Diffusion and Perfusion MRI to Differentiate Treatment Related Changes Including Pseudoprogression from Recurrent Tumors in High Grade Gliomas with Histopathologic Evidence

Diffusion and Perfusion MRI to Differentiate Treatment Related Changes Including Pseudoprogression from Recurrent Tumors in High Grade Gliomas with Histopathologic Evidence

... consisted of 68 consecutive patients with HGG according to the following inclusion criteria: 1 diagnosis of primary glioblastoma or anaplastic astrocytoma, 2 treatment with RT and temozo[r] ...

9

Developments in anaplastic large-cell lymphoma: targeting the anaplastic lymphoma kinase

Developments in anaplastic large-cell lymphoma: targeting the anaplastic lymphoma kinase

... Abstract: Anaplastic lymphoma kinase (ALK) is a receptor tyrosine kinase protein implicated in a variety of hematological malignancies and solid tumors. ALK contributes to the development of cancers in different ...

11

Breast implant-associated anaplastic large cell lymphoma in a Li-FRAUMENI patient: a case report

Breast implant-associated anaplastic large cell lymphoma in a Li-FRAUMENI patient: a case report

... ALK-negative anaplastic large cell lymphomas (ALCL, ALK-) are CD30+ T-cell neoplasms, which lack anaplastic large cell lymphoma kin- ase (ALK) rearrangement and corresponding protein ...implant-associated ...

6

Manifestations of pilocytic astrocytoma: a pictorial review

Manifestations of pilocytic astrocytoma: a pictorial review

... The goal of surgery in cases of chiasmatic/hypothalamic PA is primarily to establish a histological diagnosis; if a typical low-grade astrocytoma is encountered, then limited resection is performed. Large masses ...

16

Evaluation of prognostic factors in Wilms tumour.

Evaluation of prognostic factors in Wilms tumour.

... As a result of the NWTSG and SIOP studies the role of surgery has been customized though not eliminated. Radiation was an important treatment modality in preoperative and adjuvant settings in the earlier studies. With ...

78

Astrocytoma in an Infant with Prolonged Apnea

Astrocytoma in an Infant with Prolonged Apnea

... report a case of an infant who experienced pro- longed apnea at 4 weeks of age in whom an astro- cytoma was diagnosed at 14 months of age.. CASE REPORT.[r] ...

5

Molecular Profile of Tumours with an Oligodendroglial Morphology: Clinical Relevance

Molecular Profile of Tumours with an Oligodendroglial Morphology: Clinical Relevance

... with anaplastic oligodendroglioma and anaplastic oligoastrocytomas were included and randomized to two ...of anaplastic oligodendrogliomas while only 24% in anaplastic oligoastrocytoma showed ...

141

Radiologic pathologic correlation: intracranial astrocytoma

Radiologic pathologic correlation: intracranial astrocytoma

... Altho ugh discreet tumor foci are not identifiable amid the edema, pathology showed a well-defined tumor focus along the most lateral aspect of this abnormality where no normal gray matt[r] ...

8

Pilomyxoid Astrocytoma: Expanding the Imaging Spectrum

Pilomyxoid Astrocytoma: Expanding the Imaging Spectrum

... PMA has a strong geographic predilection for the hypothalamic/chiasmatic region.2,11 The first case series reporting imaging findings in 4 patients with PMA described a solid hypothalami[r] ...

6

Persistent Infection of Human Oligodendrocytic and Neuroglial Cell Lines by Human Coronavirus 229E

Persistent Infection of Human Oligodendrocytic and Neuroglial Cell Lines by Human Coronavirus 229E

... Human coronaviruses (HuCV) cause common colds. Previous reports suggest that these infectious agents may be neurotropic in humans, as they are for some mammals. With the long-term aim of providing experi- mental evidence ...

12

Diagnosis and Treatment of Anaplastic Thyroid Carcinoma

Diagnosis and Treatment of Anaplastic Thyroid Carcinoma

... Anaplastic thyroid cancer (ATC) is a rare malignancy which behaves aggressively. Currently, FNAC is useful for diagnosis and tumor markers (cytokeratin, vimentin, and carcinoembryogenic antigen) help in diagnosis ...

5

Show all 451 documents...

Related subjects